VOXCELL

Trademark usage description

biologically compatible materials, namely hydrogels, polymers, and related materials used for 3d tissue models, vascular structures, scaffolds, polyme Read More

Classification Information

Class [001]
Biologically compatible materials, namely hydrogels, polymers, and related materials used for 3D tissue models, vascular structures, scaffolds, polymeric networks, and/or biological tissue specimens capable of mimicking different types of human tissues for medical use and/or scientific research; biological tissue cultures for medical purposes; tissue-regenerative pharmaceutical preparations; and biological products made from such material.

Classification kind code

Class [005]
Pharmaceutical preparations and screening, namely hydrogels, polymers, and related preparations used for 3D bioprinting tissue models, vascular structures, scaffolds, polymeric networks, and/or biological tissue specimens capable of mimicking different types of human tissues for medical and scientific use; biological tissue cultures for medical purposes; tissue-regenerative pharmaceutical preparations; and pharmaceutical products made with such preparations.

Classification kind code

Class [042]
Scientific research; biological research; scientific and technological consulting services and research and design relating thereto in the fields of cell biology and life science research; research, design and development of tools for tissue testing; research, design and development of instruments and devices for cell research; research, design and development for instruments and devices for 3D bioprinting; research, design and development of tools for 3D printing of biologic products, biological tissues and proteins.

Classification kind code

Mark Details

Serial Number

2254247

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 1^st Jan 2025	Agent Changed
Submitted for opposition 287 on 11^th May 2023	Pre-Assessment Letter Sent
Submitted for opposition 30 on 26^th Apr 2023	Filed
Submitted for opposition 1 on 26^th Apr 2023	Created
Submitted for opposition 31 on 26^th Apr 2023	Formalized